Background First‐line treatment for autoimmune hepatitis (AIH) typically includes
corticosteroids in combination with azathioprine. Mycophenolate mofetil (MMF) is often used …

Autoimmune hepatitis (AIH) is a rare immune‐mediated liver disease with few major
advances in treatment options over the last several decades. Available options are effective …

Guiqiang Wang1, 18· Atsushi Tanaka2· Hong Zhao1, 1 8· Jidong Jia3· Xiong Ma4· Kenichi
Harada5· Fu‑Sheng Wang6· Lai Wei7· Qixia Wang4· Ying Sun6· Yuan Hong1· Huiying …

Background & Aims Patients with autoimmune hepatitis (AIH) almost invariably require
lifelong immunosuppressive treatment. There is genuine concern about the efficacy and …

Immunosuppressant is a class of medicines that inhibit or decrease the intensity of the
immune response in the body. Most of these medications are used to allow the body less …

ICI-related hepatotoxicity (IRH) is becoming more and more common as immune checkpoint
inhibitors (ICIs) have begun to be increasingly approved and used in combination with other …

Autoimmune hepatitis is a corticosteroid-responsive liver disease arising consequent to
immunogenetic and environmental risk factors. The clinical course reflects relapsing and …

Autoimmune hepatitis is an immune-mediated disorder characterised by
hypergammaglobulinaemia, autoantibodies, and interface hepatitis. The mainstay of …

Autoimmune diseases, induced by dysfunction of the adaptive immune system, are the
common disease categories worldwide. Recently, regulatory T cells (Tregs) enhancing …

Autoimmune hepatitis is a chronic inflammatory disease of the liver. The etiology is partly
unknown and commonly affects women of all ages. It is characterised by increase in …